Stock TBIO TRANSLATE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Translate Bio, Inc.

Equities

TBIO

US89374L1044

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Translate Bio : Sanofi Completes Translate Bio Buyout
MT
Sanofi completed the acquisition of remaining 95.1% stake in Translate Bio, Inc. from The Baupost Group, LLC, Ronald Renaud and other shareholders.
CI
VC Daily : Laronde Fundraising Haul Reflects Search for Next Moderna
DJ
Translate Bio, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
AstraZeneca : Analysis-Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow
RE
GlaxoSmithKline : Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
GlaxoSmithKline : Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
Translate Bio Shares Surge on Takeover by Sanofi
DJ
Sanofi : to Acquire Translate Bio in $3.2 Billion Deal
MT
Translate Bio : Sanofi makes $3.2 bln offer for U.S. mRNA partner Translate Bio
RE
Sanofi to Buy Translate Bio to Accelerate mRNA-Technology Use
DJ
Sanofi Reportedly Offers to Acquire Translate Bio
CI
Sanofi entered into a definitive agreement to acquire remaining 93.5% stake in Translate Bio, Inc. from The Baupost Group, LLC, Ronald Renaud and other shareholders for $2.7 billion.
CI
Translate Bio : Sanofi offers to buy U.S. biotech, mRNA partner Translate Bio -sources
RE
Sanofi : to Invest 400 Million Euros Annually in mRNA Vaccines Facility
MT
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of Mrna Influenza Vaccine
CI
Translate Bio Announces It Has Achieved A Manufacturing Milestone Under the Collaboration with Sanofi Pasteur
CI
Translate Bio Presents Preclinical Results in Primary Ciliary Dyskinesia at American Thoracic Society 2021 International Conference
CI
Translate Bio, Inc. Announces the Start of the Phase 1/2 Clinical Trial for MRT5500
CI
Translate Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Translate Bio, Inc.
  5. Highlights